Danica Pension Livsforsikringsaktieselskab Takes Position in Alignment Healthcare, Inc. $ALHC

Danica Pension Livsforsikringsaktieselskab purchased a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 3,687,259 shares of the company’s stock, valued at approximately $87,794,000. Alignment Healthcare accounts for 1.4% of Danica Pension Livsforsikringsaktieselskab’s investment portfolio, making the stock its 11th largest position.

Other institutional investors have also recently bought and sold shares of the company. Royal Bank of Canada lifted its stake in Alignment Healthcare by 92.6% during the first quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock valued at $1,720,000 after buying an additional 44,413 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Alignment Healthcare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after acquiring an additional 2,594 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Alignment Healthcare by 79.1% in the first quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock worth $18,112,000 after acquiring an additional 429,703 shares in the last quarter. Woodline Partners LP acquired a new stake in shares of Alignment Healthcare during the first quarter valued at approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Alignment Healthcare by 16.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock valued at $5,729,000 after acquiring an additional 44,452 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Insider Activity

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $19.55, for a total value of $586,500.00. Following the completion of the sale, the president directly owned 947,313 shares in the company, valued at $18,519,969.15. The trade was a 3.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider owned 331,750 shares of the company’s stock, valued at $6,588,555. This represents a 9.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,009,951 shares of company stock valued at $18,597,287. 5.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ALHC. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Alignment Healthcare in a research report on Tuesday, August 4th. UBS Group reissued a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. Barclays reduced their target price on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Alignment Healthcare in a research report on Monday, August 3rd. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $23.60.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $13.23 on Wednesday. Alignment Healthcare, Inc. has a fifty-two week low of $13.05 and a fifty-two week high of $25.12. The stock’s 50-day moving average is $19.27 and its two-hundred day moving average is $19.00. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The firm has a market cap of $2.74 billion, a P/E ratio of 69.64 and a beta of 1.10.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The firm’s revenue was up 31.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.07 EPS. Analysts predict that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current fiscal year.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.